Literature DB >> 26496836

Erratum to: Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression.

Xi Chen1,2, Hannah V McCue1, Shi Quan Wong1, Sudhanva S Kashyap1, Brian C Kraemer3, Jeff W Barclay1, Robert D Burgoyne1, Alan Morgan4.   

Abstract

The original version of this article [1] unfortunately contained a mistake. The author list contained a spelling error for the author Hannah V. McCue. The original article has been corrected for this error. The corrected author list is given below:Xi Chen, Hannah V. McCue, Shi Quan Wong, Sudhanva S. Kashyap, Brian C. Kraemer, Jeff W. Barclay, Robert D. Burgoyne and Alan Morgan

Entities:  

Year:  2015        PMID： 26496836      PMCID： PMC4619536          DOI： 10.1186/s13024-015-0051-6

Source DB:  PubMed          Journal:  Mol Neurodegener        ISSN： 1750-1326            Impact factor:   14.195


The original version of this article [1] unfortunately contained a mistake. The author list contained a spelling error for the author Hannah V. McCue. The original article has been corrected for this error. The corrected author list is given below: Xi Chen, Hannah V. McCue, Shi Quan Wong, Sudhanva S. Kashyap, Brian C. Kraemer, Jeff W. Barclay, Robert D. Burgoyne and Alan Morgan
  1 in total

1.  Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression.

Authors:  Xi Chen; Hannah V McCue; Shi Quan Wong; Sudhanva S Kashyap; Brian C Kraemer; Jeff W Barclay; Robert D Burgoyne; Alan Morgan
Journal:  Mol Neurodegener       Date:  2015-09-29       Impact factor: 14.195
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.